Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network

Posted on by sHq_LoGiNz

PARIS and CHICAGO and NASHVILLE, Tenn., April 3, 2025 /PRNewswire/ — Therapixel, creators of MammoScreen®, a leading artificial intelligence (AI) solution for breast cancer screening, today announced a strategic partnership with Onsite Women’s Health, one of the nation’s largest…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.